![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/26 | |
A61P 3/08 | |||
C07K 14/605 |
(11) | Number of the document | 2694095 |
(13) | Kind of document | T |
(96) | European patent application number | 12768072.6 |
Date of filing the European patent application | 2012-04-05 | |
(97) | Date of publication of the European application | 2014-02-12 |
(45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/032441 |
Date | 2012-04-05 |
(87) | Number | WO 2012/138941 |
Date | 2012-10-11 |
(30) | Number | Date | Country code |
201161472149 P | 2011-04-05 | US | |
201161540526 P | 2011-09-28 | US |
(72) |
SHANDLER, Scott, US
GELLMAN, Samuel H, US
|
(73) |
Longevity Biotech, Inc.,
3624 Market Street Suite 300, Philadelphia, PA 19104,
US
|
(54) | COMPOSITIONS COMPRISING GLUCAGON ANALOGS AND METHODS OF MAKING AND USING THE SAME |
COMPOSITIONS COMPRISING GLUCAGON ANALOGS AND METHODS OF MAKING AND USING THE SAME |